Director Deval L Patrick sold $1.5M of Cerevel Therapeutics Holdings, Inc.

Sold$1,468,422

$30.78Price

47,705Shares

−100%Stake

What CERE did after the filing

Prices for CERE after this filing aren't in yet.

Traded Mon, Sep 12. Filed Wed, Sep 14, 5:10 PM ET, after the close. Not investment advice.